In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Grupo Juste SAQF

www.grupojuste.com/en

Latest From Grupo Juste SAQF

Pharmanova to commercialise MediGene's Veregen in South-eastern Europe

Germany's MediGene has signed yet another agreement for its treatment for genital warts, Veregen ointment (previously Polyphenon E), the latest deal being with Serbian company, Pharmanova, which will supply and commercialise the product in South-eastern Europe. The territories covered by the agreement include Serbia, Bosnia and Herzegovina, Montenegro, Macedonia, Croatia, Slovenia, and Albania.

Venezuela

MediGene licenses Veregen in Taiwan

The German biotech company MediGene has signed another licence and supply agreement for the commercialisation and marketing of Veregen (previously Polyphenon E) ointment for the treatment of genital warts, this time with SynCore Biotechnology in Taiwan.

Venezuela

Deals Shaping the Medical Industry (05/2010)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

Deals Shaping the Medical Industry (03/2010)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
  • Therapeutic Areas
  • Gynecological, Urological
  • Neurology, Nervous System
  • Alias(es)
  • Juste SAQF
  • Juste Quimico-Farmaceutica
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Spain
  • Company Type
  • Midsize European
  • Parent & Subsidiaries
  • Grupo Juste SAQF
  • Senior Management
  • Vicente Carvajal, Dir., Bus. Dev.
  • Contact Info
  • Grupo Juste SAQF
    Phone: (34) 91 724 8200
    J. Ignacio Lucade Tena, 8
    Madrid, 28027
    Spain
Advertisement
Advertisement
UsernamePublicRestriction

Register